Free Trial
NASDAQ:ELAB

Elevai Labs 5/14/2025 Earnings Report

Elevai Labs logo
$2.21 +0.07 (+3.27%)
As of 06/4/2025 03:59 PM Eastern

Elevai Labs EPS Results

Actual EPS
-$2.90
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Elevai Labs Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Elevai Labs Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Elevai Labs Earnings Headlines

Elevai Labs (NASDAQ:ELAB) Trading Down 10.2% - What's Next?
Big Oil’s big pivot
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
See More Elevai Labs Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elevai Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevai Labs and other key companies, straight to your email.

About Elevai Labs

Elevai Labs (NASDAQ:ELAB), a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

View Elevai Labs Profile

More Earnings Resources from MarketBeat